4D Molecular Therapeutics, Inc. (FDMT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 3.05M | 85.09M | 90K | 15K | 14K | 1K | 3K | 5K | 28K | -19K | 20.2M | 239K |
| Revenue Growth % | 21664.29% | 8508900% | 2900% | 200% | -50% | 105.26% | -99.99% | -97.91% | -90.6% | -101.52% | 3940.8% | 47.53% |
| Cost of Goods Sold | 2.06M | 1.98M | 47.24M | 47.95M | 0 | 1.78M | 0 | 31.86M | 27.87M | 26.03M | 25.07M | 23.58M |
| COGS % of Revenue | 67.44% | 2.33% | 52486.67% | 319673.33% | - | 178400% | - | 637200% | 99535.71% | -136989.47% | 124.06% | 9867.78% |
| Gross Profit | 992K | 83.11M | -47.15M | -47.94M | 14K | -1.78M | 3K | -31.86M | -27.84M | -26.05M | -4.86M | -23.34M |
| Gross Margin % | 32.56% | 97.67% | -52386.67% | -319573.33% | 100% | -178300% | 100% | -637100% | -99435.71% | 137089.47% | -24.06% | -9767.78% |
| Gross Profit Growth % | 6985.71% | 4761.25% | -1571700% | -50.48% | 100.05% | 93.15% | 100.06% | -36.45% | -25.9% | -28.61% | 73.63% | -15.23% |
| Operating Expenses | 74.61M | 68.39M | 14.04M | 11.52M | 53.63M | 54.33M | 51.13M | 10.6M | 10.29M | 10.61M | 9.11M | 8.79M |
| OpEx % of Revenue | 2448.7% | 80.38% | 15596.67% | 76800% | 383107.14% | 5433400% | 1704500% | 212020% | 36764.29% | -55815.79% | 45.1% | 3678.24% |
| Selling, General & Admin | 11.69M | 12.77M | 11.84M | 11.52M | 12.94M | 14.63M | 12.65M | 10.6M | 10.29M | 10.61M | 9.11M | 8.79M |
| SG&A % of Revenue | 383.56% | 15% | 13152.22% | 76800% | 92400% | 1462700% | 421700% | 212020% | 36764.29% | -55815.79% | 45.1% | 3678.24% |
| Research & Development | 64.98M | 57.61M | 49.44M | 47.95M | 40.7M | 43.09M | 38.48M | 31.86M | 27.87M | 26.03M | 25.07M | 23.58M |
| R&D % of Revenue | 2132.59% | 67.7% | 54931.11% | 319673.33% | 290707.14% | 4308500% | 1282800% | 637200% | 99535.71% | -136989.47% | 124.06% | 9867.78% |
| Other Operating Expenses | -1000K | -1000K | -1000K | -1000K | 0 | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -73.62M | 14.71M | -61.19M | -59.46M | -53.62M | -56.12M | -51.13M | -42.46M | -38.14M | -36.65M | -13.97M | -32.14M |
| Operating Margin % | -2416.15% | 17.29% | -67983.33% | -396373.33% | -383007.14% | -5611700% | -1704400% | -849120% | -136200% | 192905.26% | -69.16% | -13446.03% |
| Operating Income Growth % | -37.3% | 126.22% | -19.66% | -40.04% | -40.6% | -53.11% | -265.91% | -32.11% | -26.67% | -27.62% | 47.26% | -13.05% |
| EBITDA | -71.56M | 10.53M | -59.92M | -58.29M | -51.87M | -61.04M | -49.43M | -41.26M | -36.96M | -35.55M | -12.98M | -31.06M |
| EBITDA Margin % | -2348.7% | 12.38% | -66582.22% | -388600% | -370478.57% | -6103800% | -1647633.33% | -825240% | -132010.71% | 187105.26% | -64.24% | -12994.56% |
| EBITDA Growth % | -37.98% | 117.26% | -21.23% | -41.27% | -40.32% | -71.7% | -280.81% | -32.86% | -27.12% | -28.31% | 50.03% | -11.08% |
| D&A (Non-Cash Add-back) | 2.06M | -4.18M | 1.26M | 1.17M | 1.75M | -4.92M | 1.7M | 1.19M | 1.17M | 1.1M | 994K | 1.08M |
| EBIT | -73.62M | 10.41M | -56.88M | -59.46M | -53.62M | -56.12M | -51.13M | -42.46M | -38.14M | -36.65M | -13.97M | -32.14M |
| Net Interest Income | 4.86M | 4.7M | 4.33M | 4.86M | 5.58M | 6.47M | 7.29M | 7.55M | 5.75M | 4.38M | 3.88M | 2.51M |
| Interest Income | 4.86M | 4.7M | 4.33M | 4.86M | 5.58M | 6.47M | 7.29M | 7.55M | 5.75M | 4.38M | 3.88M | 2.51M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.86M | 4.68M | 4.31M | 4.8M | 5.65M | 6.45M | 7.29M | 7.5M | 5.74M | 4.37M | 3.72M | 2.52M |
| Pretax Income | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M |
| Pretax Margin % | -2256.65% | 22.8% | -63195.56% | -364386.67% | -342657.14% | -4967100% | -1461433.33% | -699060% | -115717.86% | 169910.53% | -50.76% | -12391.63% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M |
| Net Margin % | -2256.65% | 22.8% | -63195.56% | -364386.67% | -342657.14% | -4967100% | -1461433.33% | -699060% | -115717.86% | 169910.53% | -50.76% | -12391.63% |
| Net Income Growth % | -43.33% | 139.05% | -29.73% | -56.38% | -48.06% | -53.86% | -327.49% | -18.02% | -12.97% | -17.91% | 60.08% | -5.45% |
| Net Income (Continuing) | -68.76M | 19.4M | -56.88M | -54.66M | -47.97M | -49.67M | -43.84M | -34.95M | -32.4M | -32.28M | -10.26M | -29.62M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 |
| EPS Growth % | -17.44% | 137.78% | -27.85% | -55.56% | -30.3% | -8.43% | -229.17% | 18.18% | 20.48% | 1.19% | 67.57% | 9.41% |
| EPS (Basic) | -1.01 | 0.34 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 | -0.83 | -0.24 | -0.77 |
| Diluted Shares Outstanding | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M |
| Basic Shares Outstanding | 68.06M | 57.93M | 56.13M | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |